Life Cycle Considerations in Hypoparathyroidism-Recorded Q&A Session with the Faculty

Video Transcription

Video Summary

In a live Q&A session, Dr. Bart L. Clark and Dr. Vafa Tabatabi, both experts in endocrinology, addressed various aspects of managing hypoparathyroidism. Key topics included appropriate calcium supplements, with a preference for calcium citrate due to better absorption, and the management of hyperphosphatemia through dietary adjustments and calcium supplements during meals. The panel discussed the necessity of magnesium supplementation based on individual patient needs and the importance of maintaining 25-hydroxyvitamin D levels to support potential extra-skeletal benefits.<br /><br />Dr. Clark highlighted that hypoparathyroidism can occasionally resolve spontaneously, particularly in cases of autoimmune origins. They also discussed the need for genetic testing in younger patients or those with syndromic features or family history. The panel emphasized the value of parathyroid hormone analogs in managing phosphorus levels and discussed the potential future availability and insurance challenges of new treatments. <br /><br />The experts addressed dietary considerations, involving dieticians primarily for managing hyperphosphatemia rather than routine care. They also highlighted the importance of monitoring bone density, particularly in postmenopausal women, due to the risk of rapid bone loss. The session concluded with a call for continuous learning and sharing of rare findings through case studies.

Keywords

hypoparathyroidism

calcium citrate

hyperphosphatemia

magnesium supplementation

25-hydroxyvitamin D

genetic testing

parathyroid hormone analogs

bone density


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274